{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T16:48:38Z","timestamp":1776012518577,"version":"3.50.1"},"posted":{"date-parts":[[2024,9,19]]},"group-title":"Molecular Biology","reference-count":36,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,9,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Incidences of fluconazole (FLC) resistance among\n                  <jats:italic>Candida glabrata<\/jats:italic>\n                  clinical isolates is a growing issue in clinics. The pleiotropic drug response (PDR) network in\n                  <jats:italic>C<\/jats:italic>\n                  .\n                  <jats:italic>glabrata<\/jats:italic>\n                  confers azole resistance and is defined primarily by the Zn\n                  <jats:sup>2<\/jats:sup>\n                  Cys\n                  <jats:sub>6<\/jats:sub>\n                  zinc cluster-containing transcription factor Pdr1 and target genes such as\n                  <jats:italic>CDR1<\/jats:italic>\n                  , that encodes an ATP-binding cassette transporter protein thought to act as a FLC efflux pump. Mutations in the\n                  <jats:italic>PDR1<\/jats:italic>\n                  gene that render the transcription factor hyperactive are the most common cause of fluconazole resistance among clinical isolates. The phenothiazine class drug fluphenazine and a molecular derivative, CWHM-974, which both exhibit antifungal properties, have been shown to induce the expression of Cdr1 in\n                  <jats:italic>Candida<\/jats:italic>\n                  spp. We have used a firefly luciferase reporter gene driven by the\n                  <jats:italic>CDR1<\/jats:italic>\n                  promoter to demonstrate two distinct patterns of\n                  <jats:italic>CDR1<\/jats:italic>\n                  promoter activation kinetics: gradual promoter activation kinetics that occur in response to ergosterol limitations imposed by exposure to azole and polyene class antifungals and a robust and rapid\n                  <jats:italic>CDR1<\/jats:italic>\n                  induction occurring in response to the stress imposed by fluphenazines. We can attribute these different patterns of\n                  <jats:italic>CDR1<\/jats:italic>\n                  induction as proceeding through the promoter region of this gene since this is the only segment of the gene included in the luciferase reporter construct. Genetic analysis indicates that the signaling pathways responsible for phenothiazine and azole induction of\n                  <jats:italic>CDR1<\/jats:italic>\n                  overlap but are not identical. The short time course of phenothiazine induction suggests that these compounds may act more directly on the Pdr1 protein to stimulate its activity.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Importance<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Candida glabrata<\/jats:italic>\n                    has emerged as the second-leading cause of candidiasis due in part to its ability to acquire high level resistance to azole drugs, a major class of antifungal, that acts to block the biosynthesis of the fungal sterol ergosterol. The presence of azole drugs causes the induction of a variety of genes involved in controlling susceptibility to this drug class including drug transporters and ergosterol biosynthetic genes such as\n                    <jats:italic>ERG11<\/jats:italic>\n                    . We found that the presence of azole drugs leads to an induction of genes encoding drug transporters and\n                    <jats:italic>ERG11<\/jats:italic>\n                    , while exposure of\n                    <jats:italic>C. glabrata<\/jats:italic>\n                    cells to antifungals of the phenothiazine class of drugs caused a much faster and larger induction of drug transporters but not\n                    <jats:italic>ERG11<\/jats:italic>\n                    . Coupled with further genetic analyses of the effects of azole and phenothiazine drugs, our data indicate that these compounds are sensed and responded to differentially in the yeast cell.\n                  <\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.09.19.613905","type":"posted-content","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:26:03Z","timestamp":1726791963000},"source":"Crossref","is-referenced-by-count":1,"title":["Similarities and distinctions in the activation of the\n                  <i>Candida glabrata<\/i>\n                  Pdr1 regulatory pathway by azole and non-azole drugs"],"prefix":"10.64898","author":[{"given":"Thomas P.","family":"Conway","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao Gia","family":"Vu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0633-2618","authenticated-orcid":false,"given":"Sarah R.","family":"Beattie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6330-3365","authenticated-orcid":false,"given":"Damian J.","family":"Krysan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7163-1120","authenticated-orcid":false,"given":"W. Scott","family":"Moye-Rowley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024092403501431000_2024.09.19.613905v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2015.10.012"},{"key":"2024092403501431000_2024.09.19.613905v1.2","doi-asserted-by":"crossref","unstructured":"Benedict K , Tsay SV , Bartoces MG , Vallabhaneni S , Jackson BR , Hicks LA. 2022. Outpatient Antifungal Prescribing Patterns in the United States, 2018. Antimicrob Steward Healthc Epidemiol 1.","DOI":"10.1017\/ash.2021.201"},{"key":"2024092403501431000_2024.09.19.613905v1.3","doi-asserted-by":"crossref","first-page":"e0002123","DOI":"10.1128\/mmbr.00021-23","article-title":"Candida albicans and Candida glabrata: global priority pathogens","volume":"88","year":"2024","journal-title":"Microbiol Mol Biol Rev"},{"key":"2024092403501431000_2024.09.19.613905v1.4","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00925-15"},{"key":"2024092403501431000_2024.09.19.613905v1.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2443.2010.01470.x"},{"key":"2024092403501431000_2024.09.19.613905v1.6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.10.3773-3781.2004"},{"key":"2024092403501431000_2024.09.19.613905v1.7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.4.1384-1392.2006"},{"key":"2024092403501431000_2024.09.19.613905v1.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2006.05235.x"},{"key":"2024092403501431000_2024.09.19.613905v1.9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000268"},{"key":"2024092403501431000_2024.09.19.613905v1.10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02217-13"},{"key":"2024092403501431000_2024.09.19.613905v1.11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009582"},{"key":"2024092403501431000_2024.09.19.613905v1.12","doi-asserted-by":"crossref","first-page":"e0209821","DOI":"10.1128\/aac.02098-21","article-title":"Azole-Resistant Alleles of ERG11 in Candida glabrata Trigger Activation of the Pdr1 and Upc2A Transcription Factors","volume":"66","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2024092403501431000_2024.09.19.613905v1.13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.5.834"},{"key":"2024092403501431000_2024.09.19.613905v1.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2007.01371.x"},{"key":"2024092403501431000_2024.09.19.613905v1.15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.3064-3079.2004"},{"key":"2024092403501431000_2024.09.19.613905v1.16","doi-asserted-by":"crossref","unstructured":"A KR, Shah AH , Prasad R . 2016. MFS transporters of Candida species and their role in clinical drug resistance. FEMS Yeast Res 16.","DOI":"10.1093\/femsyr\/fow043"},{"key":"2024092403501431000_2024.09.19.613905v1.17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/acsinfecdis.7b00157","article-title":"Antifungal Phenothiazines: Optimization, Characterization of Mechanism, and Modulation of Neuroreceptor Activity","volume":"4","year":"2018","journal-title":"ACS Infect Dis"},{"key":"2024092403501431000_2024.09.19.613905v1.18","doi-asserted-by":"crossref","first-page":"e0056723","DOI":"10.1128\/aac.00567-23","article-title":"CWHM-974 is a fluphenazine derivative with improved antifungal activity against Candida albicans due to reduced susceptibility to multidrug transporter-mediated resistance mechanisms","volume":"67","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"2024092403501431000_2024.09.19.613905v1.19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-0716-3155-3_11","article-title":"Characterizing Candida glabrata Pdr1, a Hyperactive Transcription Factor Involved in Azole Resistance","volume":"2658","year":"2023","journal-title":"Methods Mol Biol"},{"key":"2024092403501431000_2024.09.19.613905v1.20","doi-asserted-by":"publisher","DOI":"10.1002\/yea.1024"},{"key":"2024092403501431000_2024.09.19.613905v1.21","doi-asserted-by":"crossref","first-page":"e0241623","DOI":"10.1128\/mbio.02416-23","article-title":"Calcineurin is required for Candida glabrata Pdr1 transcriptional activation","volume":"14","year":"2023","journal-title":"mBio"},{"key":"2024092403501431000_2024.09.19.613905v1.22","doi-asserted-by":"crossref","unstructured":"Vu BG , Thomas GH , Moye-Rowley WS . 2019. Evidence that Ergosterol Biosynthesis Modulates Activity of the Pdr1 Transcription Factor in Candida glabrata. MBio 10.","DOI":"10.1128\/mBio.00934-19"},{"key":"2024092403501431000_2024.09.19.613905v1.23","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00277-10"},{"key":"2024092403501431000_2024.09.19.613905v1.24","doi-asserted-by":"crossref","first-page":"e0025423","DOI":"10.1128\/msphere.00254-23","article-title":"Redefining pleiotropic drug resistance in a pathogenic yeast: Pdr1 functions as a sensor of cellular stresses in Candida glabrata","volume":"8","year":"2023","journal-title":"mSphere"},{"key":"2024092403501431000_2024.09.19.613905v1.25","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/iyae115"},{"key":"2024092403501431000_2024.09.19.613905v1.26","doi-asserted-by":"crossref","first-page":"e1009005","DOI":"10.1371\/journal.pgen.1009005","article-title":"Functional information from clinically-derived drug resistant forms of the Candida glabrata Pdr1 transcription factor","volume":"16","year":"2020","journal-title":"PLoS Genet"},{"key":"2024092403501431000_2024.09.19.613905v1.27","doi-asserted-by":"crossref","unstructured":"Vu BG , Moye-Rowley WS . 2022. Nonidentical function of Upc2A binding sites in the Candida glabrata CDR1 promoter. Genetics 222.","DOI":"10.1093\/genetics\/iyac135"},{"key":"2024092403501431000_2024.09.19.613905v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/nature06836"},{"key":"2024092403501431000_2024.09.19.613905v1.29","doi-asserted-by":"crossref","unstructured":"Liu Z , Myers LC . 2017. Mediator Tail Module Is Required for Tac1-Activated CDR1 Expression and Azole Resistance in Candida albicans. Antimicrob Agents Chemother 61.","DOI":"10.1128\/AAC.01342-17"},{"key":"2024092403501431000_2024.09.19.613905v1.30","doi-asserted-by":"publisher","DOI":"10.1111\/mmi.14109"},{"key":"2024092403501431000_2024.09.19.613905v1.31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2003.03495.x"},{"key":"2024092403501431000_2024.09.19.613905v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2019.08.004"},{"key":"2024092403501431000_2024.09.19.613905v1.33","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00535-10"},{"key":"2024092403501431000_2024.09.19.613905v1.34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s44259-023-00007-2","article-title":"Molecular mechanisms governing antifungal drug resistance","volume":"1","year":"2023","journal-title":"NPJ Antimicrob Resist"},{"key":"2024092403501431000_2024.09.19.613905v1.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2007.01710.x"},{"key":"2024092403501431000_2024.09.19.613905v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(02)00087-X"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.09.19.613905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:05:03Z","timestamp":1768460703000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.09.19.613905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1101\/2024.09.19.613905","relation":{},"subject":[],"published":{"date-parts":[[2024,9,19]]},"subtype":"preprint"}}